Plasma Cell Disorders (part 2)
Author and Disclosure Information [Show]

Blood Cancer and BMT Program, Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO

Question 1 of 5

Questions 1 and 2 are based on the following case:

A 71-year-old man with a history of hypertension and an elevated prostate-specific antigen (PSA) level that is under observation reports increasing low back pain to his primary care physician. The pain initially started as an ache, but over the past 2 months has reached a 7/10 level. The pain does not radiate. A trial of ibuprofen and physical therapy for 3 weeks does not relieve the pain. The patient is referred for magnetic resonance imaging (MRI) of the lumbar spine; an image on a coronal T2-weighted section from that evaluation is shown in the Figure. His primary care physician next orders a nuclear bone scan, which comes back negative.

T2-weighted image from magnetic resonance imaging evaluation of patient in question 1. Image used by permission of Tomer Mark, MD.

Figure. T2-weighted image from magnetic resonance imaging evaluation of patient in question 1.

Which laboratory test would most likely be returned positive in this case?

Beta-human chorionic gonadotropin (hCG)

Carbohydrate antigen (CA) 19-9

Carcinoembryonic antigen (CEA)

QuantiFERON-TB Gold

Serum protein electrophoresis

Hospital Physician: Hematology/Oncology. 2019 January;14(1)

This quiz is not accredited for CME.

More from Board Review Questions: Hematology/Oncology


Autoimmune Hemolytic Anemia
Gastrointestinal Stromal Tumors
Testicular Cancer
Management of Advanced Melanoma
Castration-Resistant Prostate Cancer
Transfusion Reactions (part 2)
Transfusion Reactions (part 1)
Plasma Cell Disorders (part 3)
Chronic Myeloid Leukemia
Aplastic Anemia
Small Cell Lung Cancer
Management of Metastatic Gastric Cancer
Transfusion Medicine
Acute Myeloid Leukemia
Management of Colorectal Cancer in Older Adults
Urothelial Carcinoma: Muscle-Invasive and Metastatic Disease
Pancreatic Adenocarcinoma: Advanced Unresectable and Metastatic Disease
HER2-Positive Breast Cancer
Aggressive B-Cell Non-Hodgkin Lymphoma
Von Willebrand Disease: Assessment and Diagnostic Testing
Von Willebrand Disease: Clinical Management
Pancreatic Adenocarcinoma: Neoadjuvant and Adjuvant Treatment
Late Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Polycythemia Vera and Essential Thrombocythemia: Current Management
Treatment of Biliary Tract Cancers
Early Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Hairy Cell Leukemia
Genomic Testing in Women with Early-Stage Hormone Receptor–Positive, HER2-Negative Breast Cancer
Immune Thrombocytopenia
Cancer-Related Fatigue
Disseminated Intravascular Coagulation
Advanced Stage and Relapsed/Refractory Hodgkin Lymphoma
Adjuvant Chemotherapy for Colon Cancer
Molecular Markers and Targeted Therapies in the Management of Non-Small Cell Lung Cancer
Metastatic Cutaneous Melanoma: Targeted Therapy and Immunotherapy
Thrombosis in Pregnancy
Locally Advanced Pancreatic Cancer
Early-Stage Hodgkin Lymphoma
Neoadjuvant and Adjuvant Therapy for Gastric Cancer
Hemophilia A and B
Mantle Cell Lymphoma
Soft Tissue Sarcoma
Sickle Cell Disease
Renal Cell Carcinoma
Management of Locally Advanced Rectal Adenocarcinoma
Adjuvant Systemic Therapy for Early-Stage Breast Cancer
Chronic Myeloid Leukemia
Plasma Cell Disorders
Myelodysplastic Syndromes
Acute and Chronic Graft-versus-Host Disease